ImmuCell Corp. (ICCC)
5.90
+0.33
(+5.92%)
USD |
NASDAQ |
Dec 10, 14:33
ImmuCell EPS Diluted (Quarterly): -0.0154 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 3.404 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1397M |
| Revenue (Quarterly) | 5.506M |
| Total Expenses (Quarterly) | 5.646M |
| Enterprise Value | 60.11M |
| Gross Profit Margin (Quarterly) | 42.92% |
| Profit Margin (Quarterly) | -2.54% |
| Earnings Yield | 4.39% |
| Operating Earnings Yield | 4.39% |
| Normalized Earnings Yield | 4.388 |